TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Fibroids in pregnancy
Key Statistics
- 10.7% — Fibroid prevalence, 1ST trimester
- 48.5% — Caesarean rate with fibroids (vs 13.3%)
- 35.2% — Miscarriage rate after UAE (vs 16.5%)
Don't-miss facts
-
MBRRACE 2015: PPH = 2nd commonest cause of direct maternal death; fibroids are a key contributor via mechanical impairment of uterine contractility
-
Fibroids: caesarean rate 48.5% vs 13.3%; double the risk of placenta praevia; complications more likely if volume
200 cm³ or diameter >5 cm
-
Ulipristal acetate must be stopped before conception – antenatal exposure: 33% miscarriage, 92% caesarean section in continuing pregnancies
-
UAE should not be routinely offered pre-conception: ↑miscarriage, ↑caesarean, ↑PPH, and 11% placenta accreta risk
-
Uterine rupture after myomectomy: laparoscopic 1.2–6.8% vs open 0.4%; wait ≥6 months post-laparoscopic myomectomy before conceiving (Canadian guidance)
-
At caesarean: incise ≥2 cm from fibroids; classical incision ≥10 cm if needed for cervical fibroids
-
Caesarean myomectomy is safe and cost-effective – adds only ~15 min operating time, no ↑transfusion/fever risk vs caesarean alone
-
70% of fibroids regress by 3–6 months postpartum; less regression with Black ethnicity, progesterone-only contraception, and after miscarriage
Evidence tiers at a glance
Safe: tranexamic acid, paracetamol, opiates, cell salvage
Avoid pre-conception: UPA, GnRH agonists, danazol, aromatase inhibitors, routine UAE
Abbreviation Key
- MBRRACE — Mothers and Babies: Reducing Risk through Audits
- ECV — external cephalic version and Confidential Enquiries
- NSAID — non-steroidal anti-inflammatory drug
- PPH — postpartum haemorrhage
- VTE — venous thromboembolism
- PPROM — preterm prelabour rupture of membranes
- NEC — necrotising enterocolitis
- FGR — fetal growth restriction
- GnRH — gonadotropin-releasing hormone
- UAE — uterine artery embolisation
- OR — odds ratio
- UPA — ulipristal acetate
- CI — confidence interval
- MRI — magnetic resonance imaging
Source: Sampat K, Alleemudder DI. Fibroids in pregnancy: management and outcomes. The Obstetrician & Gynaecologist 2018;20:187–195. doi:10.1111/tog.12491
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).